Eden Bioscience (300685.SZ) shareholder Xiamen Yixiang plans to reduce its shareholding by no more than 3%.

Wisdom Finance APP News, Edmond Biotech (300685.SZ) announced that the company recently received a "Notice of Reduction Plan" issued by its shareholder Xiamen Yixiang Investment Partnership Enterprise (Limited Partnership) ("Xiamen Yixiang"), planning to reduce the number of shares by no more than 11.79 million shares, or 3.00% of the total share capital of the company.